RESI is one of the most compelling events for active early life science investors in the industry today, focused on connecting early stage life science companies with top-tier investors from the new and emerging investors in the space, including Family Offices, Venture Philanthropy, Mid-Level Private Equity, Virtual Pharmaceutical Companies, Angel Groups, and Corporate Venture.
A snapshot of the last RESI Conference: Over 140 active life science investors, 88% Executive-Level Attendees, over 400 global attendees, and 660 1-on-1 partnering meetings. Our third conference is on track to surpass March’s event attendee and investor numbers to create powerful synergistic relationships between both parties. There are still sponsorship and exhibitor opportunities available for those who want great access to cutting edge early stage life science and medtech companies.
For more information visit the RESI Website